|
Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative
|
02-12-13 |
|
Cannabis Science Working with Cannabis Caucus in the U.S. House of Representatives in the Fight to Level the Playing Field for Cannabis Drug Research and Development
|
25-11-13 |
|
Cannabis Science, Inc. (CBIS) Announces Broad Patent Licensing Agreement with Endocan Corporation (ENDO) to Develop the Cannabinoid-Based Patent N2010968 'Composition for the Treatment of Neurobehavioral Disorders' for Over-the-Counter, Dispensary, and Fo
|
21-11-13 |
|
Cannabis Science, Inc. (CBIS) Promotes Robert Kane to Chief Financial Officer (CFO), Board of Directors
|
20-11-13 |
|
Cannabis Science, Inc. (CBIS) Featured in A&U Magazine Regarding Potential Utility of Cannabinoids to Address Emerging Crisis of HIV Drug Resistance
|
18-11-13 |
|
Cannabis Science, Inc. (CBIS) Announces Submission of Cannabinoid-Based Patent Application N2010968 Titled 'Composition for the Treatment of Neurobehavioral Disorders'
|
15-11-13 |
|
Cannabis Science Announces The Depository Trust Company (DTC) Lifts Share Trading "Chill" Effective Immediately
|
06-09-13 |
|
Cannabis Science Appoints Clinical Development Expert, Dr. Dorothy Bray, as Chief Executive Officer (CEO) and Director, Focusing on CS-TATI-1 and Building Company's Drug Development Pipeline
|
29-05-13 |
|
Cannabis Science Announces Preclinical Development Program for CS-TATI-I, Commencing EU Operations in the Netherlands and Sourcing Proprietary Material for Pharmacokinetic Characterization
|
26-04-13 |
|
Cannabis Science Announces Screening of 'American Drug War II,' Film by Kevin Booth, on Thursday, April 18
|
16-04-13 |
